Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ArcLight Clean Transition was a special purpose acquisition company (SPAC) with no significant operations that aimed to merge or acquire a business in the clean energy/energy transition sector. It completed acquisitions: ArcLight Clean Transition Corp. (ACTC) merged with Proterra (electric vehicle technology), and ArcLight Clean Transition Corp. II (ACTD) merged with OPAL Fuels (renewable natural gas).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ArcLight Clean Transition.